Accordingly, rituximab was found to decrease circulating autoreactive T cells in pemphigus (47, 48), and long-lasting response to rituximab was found to rely on the decrease of DSG-specific T follicular helper cells participating in sustained depletion of memory auto-reactive B cells and DSG antibody-secreting cells (49). The gene discussed is DSG1; the disease is pemphigus.